Genetic heterogeneity of autosomal dominant hypercholesterolemia

Area of Science:

• Genetics
• Cardiovascular Medicine
• Biochemistry

Background:

• Autosomal dominant hypercholesterolemia (ADH) is characterized by elevated low-density lipoprotein cholesterol, increasing the risk of premature cardiovascular disease.
• Mutations in the LDLR and APOB genes are established causes of ADH.
• Recent discoveries include missense mutations in the PCSK9 gene contributing to ADH, highlighting genetic heterogeneity.

Purpose of the Study:

• To review and analyze the genetic heterogeneity of Autosomal dominant hypercholesterolemia (ADH).
• To evaluate the contribution of mutations in LDLR, APOB, and PCSK9 genes to ADH.
• To explore the potential involvement of unknown genes in ADH.

Main Methods:

• Review of existing literature on mutations in LDLR, APOB, and PCSK9 genes associated with ADH.
• Analysis of strategies and results from studies investigating the genetic basis of ADH.
• Synthesis of evidence regarding the genetic heterogeneity of ADH.

Main Results:

• Over 1000 mutations identified in the LDLR gene and 9 in the APOB gene.
• Discovery of missense mutations in the PCSK9 gene contributing to ADH.
• Discrepancies in the evaluated contribution of different genes, suggesting complex genetic interactions.

Conclusions:

• ADH exhibits significant genetic heterogeneity, with multiple genes implicated.
• The identified mutations in LDLR, APOB, and PCSK9 explain a portion of ADH cases.
• Evidence suggests that additional, yet unidentified genes likely play a role in the pathogenesis of ADH.